Advertisement
< Vol. 15 Issue 2 | Mar-Apr 2014 | pp. 73 - 156

Comparison of FLIXENE™ and standard PTFE arteriovenous graft for early haemodialysis

Comparison of FLIXENE™ and standard PTFE arteriovenous graft for early haemodialysis

J Vasc Access 2014; 15(2): 116 - 122

Article Type: ORIGINAL ARTICLE

Article Subject: Dialysis

DOI:10.5301/jva.5000213

Authors

Nathaniel Chiang, Katherine Ria Hulme, Paul Charles Haggart, Thodur Vasudevan

Abstract

Purpose: The purpose is to compare the outcomes of FLIXENE™ arteriovenous graft (AVG) to standard polytetrafluoroethylene (PTFE) AVG for early haemodialysis.

Methods: This is a prospective observational study of all AVGs placed over a 40-month period between 2008 and 2011 at our vascular unit. Primary outcome was to examine early cannulation rates for FLIXENE™. Secondary outcomes included patency rates, usability of grafts, complications in particular infections, interventions and death in comparison to standard PTFE grafts.

Results: Forty-five FLIXENE™ and 19 standard PTFE AVGs were placed in the study period; 89% of FLIXENE™ grafts were used for dialysis, with 78% cannulated within 3 days. At 18 months, primary patency (FLIXENE™ 34% vs standard PTFE 24%), primary assisted patency (35% vs 36%) and secondary patency rate (51% vs 48%) were not statistically different; 20.2% of FLIXENE™ grafts were infected at 18 months requiring explantation compared with 40.3% of standard PTFE grafts (p=0.14).

Conclusions: FLIXENE™ can be cannulated for dialysis within 3 days. It has similar patency and complication rates as other prosthetic grafts in the market. In patients who have no access and require urgent dialysis, FLIXENE™ is a viable option.

Article History

  • • Accepted on 15/12/2013
  • • Available online on 10/02/2014
  • • Published in print on 08/05/2014

Disclosures

Financial support: No competing interests or financial support declared.
Conflict of interest: None.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Chiang, Nathaniel [PubMed] [Google Scholar]
  • Hulme, Katherine Ria [PubMed] [Google Scholar] , * Corresponding Author (katherine.hulme@waikatodhb.health.nz)
  • Haggart, Paul Charles [PubMed] [Google Scholar]
  • Vasudevan, Thodur [PubMed] [Google Scholar]

Affiliations

  • Waikato Hospital, Hamilton - New Zealand

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.